Education
About Us
Working with TipRanks
Follow Us
Enanta Pharmaceuticals (ENTA)
NASDAQ:ENTA
Enanta Pharmaceuticals (ENTA) Ownership Overview
6.75% Insiders
14.50% Mutual Funds
22.71% Other Institutional Investors
11.25% ETFs
44.79% Public Companies and
Individual Investors
The ownership structure of Enanta Pharmaceuticals (ENTA) stock is a mix of institutional, retail, and individual investors. Approximately 48.46% of the company’s stock is owned by Institutional Investors, 6.75% is owned by Insiders, and 44.79% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Feb 12, 2025 | Jay Luly President & Ceo,director | xxxxxxxxxxxxx | $256050 |
| Dec 10, 2024 | Brendan Luu Cbo | xxxxxxxxxxxxx | $18401 |
| Dec 10, 2024 | Tara Lynn Kieffer Chief Product Strategy Officer | xxxxxxxxxxxxx | $18401 |
| Dec 10, 2024 | xxxxxxxxxxxxx | $6980 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $5968500 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,108,262 | Institution | 9.88% | 12,860,398 | |
| 1,095,991 | Institution | 5.14% | 6,685,545 | |
| 1,038,000 | Institution | 4.87% | 6,331,800 | |
| 957,374 | Institution | 4.49% | 5,839,981 | |
| 911,208 | Institution | 4.27% | 5,558,369 | |
| 864,654 | Insider | 4.05% | 5,274,389 | |
| 481,503 | Institution | 2.26% | 2,937,168 | |
| 374,535 | Insider | 1.76% | 2,284,664 | |
| 274,711 | Institution | 1.29% | 1,675,737 | |
| 223,956 | Institution | 1.05% | 1,366,132 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 911,208 | Institution | 4.27% | 5,558,369 | |
| 481,503 | Institution | 2.26% | 2,937,168 | |
| 274,711 | Institution | 1.29% | 1,675,737 | |
| 223,956 | Institution | 1.05% | 1,366,132 | |
| 205,211 | Institution | 0.96% | 1,251,787 | |
| 119,191 | Institution | 0.56% | 727,065 | |
| 109,595 | Institution | 0.51% | 668,530 | |
| 109,547 | Institution | 0.51% | 668,237 | |
| 84,628 | Institution | 0.40% | 516,231 | |
| 82,642 | Institution | 0.39% | 504,116 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 629,597 | Institution | 2.95% | 4,898,265 | |
| 542,271 | Institution | 2.54% | 3,307,853 | |
| 294,946 | Institution | 1.38% | 2,294,680 | |
| 180,254 | Institution | 0.84% | 1,099,549 | |
| 119,356 | Institution | 0.56% | 728,072 | |
| 91,986 | Institution | 0.43% | 715,651 | |
| 91,333 | Institution | 0.43% | 607,364 | |
| 63,978 | Institution | 0.30% | 497,749 | |
| 57,015 | Institution | 0.27% | 379,150 | |
| 45,529 | Institution | 0.21% | 277,727 |
FAQ
Who Owns Enanta Pharmaceuticals (ENTA)?
According to the latest TipRanks data, approximately 22.71% of the company's stock is held by institutional investors, 6.75% is held by insiders, and 44.79% is held by retail investors.
What percentage of Enanta Pharmaceuticals (ENTA) stock is held by institutional investors?
According to the latest TipRanks data, approximately 22.71% of Enanta Pharmaceuticals (ENTA) stock is held by institutional investors.
What percentage of Enanta Pharmaceuticals (ENTA) stock is held by retail investors?
According to the latest TipRanks data, approximately 44.79% of Enanta Pharmaceuticals (ENTA) stock is held by retail investors.
Who owns the most shares of Enanta Pharmaceuticals (ENTA)?
Andrew J.M. Spokes owns the most shares of Enanta Pharmaceuticals (ENTA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.